June mARKet Update Webinar Summary

In ARK Invest's June mARKet Update webinar, Founder, CIO, and CEO Cathie Wood led a discussion joined by ARK's investment professionals to unpack key developments in technology and innovation. With Tesla's robotaxi launch on the horizon, new momentum in private markets, and strategic moves across AI, biotech, and digital assets, the session offered ARK's latest insights on how transformative innovation is shaping the global investment landscape. Below is a summary of the team’s responses to investor-submitted questions. For further insights, please view the full June mARKet Update Webinar here.

The Musk And Trump Feud Appears To Be Cooling Off, But Can You Give Your Takeaways, Views, And Insights Here?

Cathie Wood opened by framing the Musk-Trump dynamic as emblematic of broader societal and market transitions. While political clashes can dominate headlines, ARK remains focused on first principles and data. Cathie emphasized Elon Musk's consistent execution across multiple fronts, from Tesla to SpaceX and Neuralink, and noted that political rhetoric is unlikely to affect materially the innovation trajectory Musk is helping to lead.

Tesla Is Scheduled To Roll Out Its Robotaxi Commercialization In Austin On June 22. How Should This Impact Tesla?

Sam Korus, ARK’s Director of Research, Autonomous Technology & Robotics, shared ARK's conviction that robotaxis could alter Tesla's valuation dramatically. Tesla’s commercialization of robotaxi service should validate years of investment in autonomous software and hardware. Sam reiterated ARK's long-held view that autonomous ride-hailing could transform transportation economics and that Tesla is best positioned to be a dominant player.

The ARK Venture Fund Has Recently Invested In Neuralink. What Is Your Thesis For The Company?

Korus explained that Neuralink exemplifies ARK's belief in convergence across sectors. Neuralink's interface between the brain and machines has profound implications across healthcare, robotics, and computing. ARK sees Neuralink as a platform company with transformative potential in neural data and brain-computer interaction.

Clients Have Observed Many New Disruptors From The Private Sectors All Around The World, Including Chips, AI Platforms, Streaming, And Fintech. Do You Think Holdings Like PLTR, COIN, Or HOOD Will Be Disrupted? How Does The ARK Research Team Weigh Innovation In Other, Younger Private Companies Compared To Some Of The Public Names You Hold?

Cathie Wood highlighted ARK's open research ecosystem and iterative approach to disruption analysis. While acknowledging that private companies are pushing boundaries in semiconductors, AI, and fintech, current ARK holdings like Palantir (PLTR), Coinbase (COIN), and Robinhood (HOOD) continue to evolve. ARK remains vigilant, continuously reassessing relative innovation trajectories, and would not hesitate to rotate capital toward younger disruptors, if they demonstrate superior execution and product-market fit.

Circle’s Recent IPO Was Impressive. Why Are Stablecoins Interesting To ARK?

Lorenzo Valente, ARK’s Director of Research, Digital Assets, underscored the pivotal role stablecoins could play in a future decentralized financial system. ARK views stablecoins as critical infrastructure enabling near-instant settlement, programmable finance, and global remittances. Circle’s IPO marks a milestone in institutional validation of this thesis, and ARK continues to explore opportunities tied to digital dollar infrastructure.

What Exposure Do Your Portfolios Have To AI Datacenters?

Frank Downing, ARK’s Director of Research, Next Generation Internet, and Jozef Soja, Research Analyst, Next Generation Internet, discussed ARK's comprehensive exposure to the AI datacenter value chain. This includes holdings in companies that supply compute infrastructure (e.g., NVIDIA), design datacenter components, or provide cloud-based AI services. The team emphasized how datacenters are becoming foundational to economic growth, akin to railroads and the internet in previous eras.

Tempus AI Has Had An Eventful Month, With Downside Volatility Driven By A Short Report Followed By An Expansion Of Tempus One And Other Positive Developments. What Are Your Thoughts On The Name In Light Of These Developments?

Nemo Marjanovic, ARK’s Research Analyst, Multiomics, stressed ARK’s continued belief in Tempus AI’s long-term value proposition. While short-term volatility is a feature of public markets, Tempus's product pipeline and data scale continue to differentiate the company. The expansion of Tempus One reinforces ARK's thesis that precision medicine platforms are critical enablers in healthcare's digital transformation.

With ARKW Heading Back Toward All-Time Highs And ARKG Still Near Its Lows, When Do You Think This Gap Will Close? Some Technologies Seem To Be Gaining Steam While Biotech Continues To Lag.

Cathie Wood concluded the Q&A by addressing performance divergence across ARK portfolios, noting that genomics historically is cyclical and currently undervalued because of macro uncertainty and regulatory lag. That said, ARK’s research suggests that the lag belies accelerating breakthroughs in gene editing, diagnostics, and cellular therapies. As investor confidence returns to the space, ARKG is poised for potential convergence with ARKW, which has seen inflows tied to broader enthusiasm around AI and internet innovation.

Conclusion

The June mARKet Update illustrated ARK's enduring commitment to investing in disruptive innovation. With a disciplined research approach and a focus on convergence across sectors, ARK continues to identify technologies that are reshaping the global economy. As always, ARK remains transparent, forward-looking, and dedicated to empowering investors with insight and opportunity.

Stay tuned to our In The Know video series for deeper insights about deflation, innovation, and macroeconomic developments.

Important Information

The information provided in this material is for informational purposes only and should not be used as the basis for any investment decision and is subject to change without notice. It does not constitute, either explicitly or implicitly, any provision of services or products by ARK, and investors should determine for themselves whether a particular investment management service is suitable for their investment needs. All statements made regarding companies or securities are strictly beliefs and points of view held by ARK and are not endorsements by ARK of any company or security or recommendations by ARK to buy, sell or hold any security. Historical results are not indications of future results. 

Certain of the statements contained in this material may be statements of future expectations and other forward-looking statements that are based on ARK's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. ARK assumes no obligation to update any forward-looking information. ARK and its clients as well as its related persons may (but do not necessarily) have financial interests in securities or issuers that are discussed. Certain information was obtained from sources that ARK believes to be reliable; however, ARK does not guarantee the accuracy or completeness of any information obtained from any third party.

To view the top ten holdings for ARKK click here.

To view the top ten holdings for ARKQ click here.

To view the top ten holdings for ARKW click here.

To view the top ten holdings for ARKG click here.

To view the top ten holdings for ARKF click here.

To view the top ten holdings for ARKX click here.

To view the top ten holdings for ARKVX click here.